Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying disease-Reference-Cited by-同舟云学术

Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying disease

Published:1983-08 Issue:2 Volume:2 Page:327-331
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Sinoway Lawrence S.,Maskin Carol S.,Chadwick Brian,Forman Robert,Sonnenblick Edmund H.,Le Jemtel Thierry H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Intravenous and oral cardiotonic activity of WIN 47203, a potent amrinone analoge in dogs (abstr);Alousi;Fed Proc,1981

2. Maskin CS, Sonnenblick EH. Inotropic drugs for the treatment of the failing heart. In: Brest NA, ed. Cardiovascular Clinics. Philadelphia: FA Davis (in press).

3. A Summary of Laboratory Data on WIN 47203,1982

4. Heart failure in outpatients. A randomized trial of digoxin versus placebo;Chia-sen Lee;N Engl J Med,1982

5. Long-term digitalis therapy improves left ventricular function in heart failure;Arnold;N Engl J Med,1980

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of milrinone on hemodynamic and gas exchange parameters in children;Cardiology in the Young;2019-12-17

2. Functions of PDE3 Isoforms in Cardiac Muscle;Journal of Cardiovascular Development and Disease;2018-02-06

3. Novel approaches to targeting PDE3 in cardiovascular disease;Pharmacology & Therapeutics;2016-07

4. New pharmacologic interventions to increase cardiac contractility;Current Opinion in Cardiology;2015-05

5. PDE3 inhibition in dilated cardiomyopathy;Current Opinion in Pharmacology;2011-12